Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial

Konstantinos Leventogiannis, Evdoxia Kyriazopoulou, Nikolaos Antonakos, Antigone Kotsaki, Iraklis Tsangaris, Dimitra Markopoulou, Inge Grondman, Nikoleta Rovina, Vassiliki Theodorou, Eleni Antoniadou, Ioannis Koutsodimitropoulos, George Dalekos, Glykeria Vlachogianni, Karolina Akinosoglou, Vassileios Koulouras, Apostolos Komnos, Theano Kontopoulou, Athanassios Prekates, Antonia Koutsoukou, Jos W.M. van der Meer, George Dimopoulos, Miltiades Kyprianou, Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis

Open source

DOI
10.1016/j.xcrm.2022.100817
Published
2022-11
Container
Cell Reports Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xcrm.2022.100817,
  title = {Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial},
  author = {Konstantinos Leventogiannis and Evdoxia Kyriazopoulou and Nikolaos Antonakos and Antigone Kotsaki and Iraklis Tsangaris and Dimitra Markopoulou and Inge Grondman and Nikoleta Rovina and Vassiliki Theodorou and Eleni Antoniadou and Ioannis Koutsodimitropoulos and George Dalekos and Glykeria Vlachogianni and Karolina Akinosoglou and Vassileios Koulouras and Apostolos Komnos and Theano Kontopoulou and Athanassios Prekates and Antonia Koutsoukou and Jos W.M. van der Meer and George Dimopoulos and Miltiades Kyprianou and Mihai G. Netea and Evangelos J. Giamarellos-Bourboulis},
  year = {2022},
  journal = {Cell Reports Medicine},
  doi = {10.1016/j.xcrm.2022.100817},
  url = {https://doi.org/10.1016/j.xcrm.2022.100817}
}

RIS

TY  - JOUR
TI  - Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial
AU  - Konstantinos Leventogiannis
AU  - Evdoxia Kyriazopoulou
AU  - Nikolaos Antonakos
AU  - Antigone Kotsaki
AU  - Iraklis Tsangaris
AU  - Dimitra Markopoulou
AU  - Inge Grondman
AU  - Nikoleta Rovina
AU  - Vassiliki Theodorou
AU  - Eleni Antoniadou
AU  - Ioannis Koutsodimitropoulos
AU  - George Dalekos
AU  - Glykeria Vlachogianni
AU  - Karolina Akinosoglou
AU  - Vassileios Koulouras
AU  - Apostolos Komnos
AU  - Theano Kontopoulou
AU  - Athanassios Prekates
AU  - Antonia Koutsoukou
AU  - Jos W.M. van der Meer
AU  - George Dimopoulos
AU  - Miltiades Kyprianou
AU  - Mihai G. Netea
AU  - Evangelos J. Giamarellos-Bourboulis
PY  - 2022
JO  - Cell Reports Medicine
DO  - 10.1016/j.xcrm.2022.100817
UR  - https://doi.org/10.1016/j.xcrm.2022.100817
ER  - 

APA

Leventogiannis, K., Kyriazopoulou, E., Antonakos, N., Kotsaki, A., Tsangaris, I., Markopoulou, D., Grondman, I., Rovina, N., Theodorou, V., Antoniadou, E., Koutsodimitropoulos, I., Dalekos, G., Vlachogianni, G., Akinosoglou, K., Koulouras, V., Komnos, A., Kontopoulou, T., Prekates, A., Koutsoukou, A., Meer, J. W. V. D., Dimopoulos, G., Kyprianou, M., Netea, M. G., & Giamarellos-Bourboulis, E. J. (2022). Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2022.100817

Source records